These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 26517092)

  • 21. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
    Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
    Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
    Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
    Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of differentially expressed signatures of long non-coding RNAs associated with different metastatic potentials in gastric cancer.
    Song W; Liu YY; Peng JJ; Liang HH; Chen HY; Chen JH; He WL; Xu JB; Cai SR; He YL
    J Gastroenterol; 2016 Feb; 51(2):119-29. PubMed ID: 26045391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Polycomb-mir200 loop regulates clinical outcome in bladder cancer.
    Martínez-Fernández M; Dueñas M; Feber A; Segovia C; García-Escudero R; Rubio C; López-Calderón FF; Díaz-García C; Villacampa F; Duarte J; Gómez-Rodriguez MJ; Castellano D; Rodriguez-Peralto JL; de la Rosa F; Beck S; Paramio JM
    Oncotarget; 2015 Dec; 6(39):42258-75. PubMed ID: 26517683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NOB1 is essential for the survival of RKO colorectal cancer cells.
    He XW; Feng T; Yin QL; Jian YW; Liu T
    World J Gastroenterol; 2015 Jan; 21(3):868-77. PubMed ID: 25624720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of new genes associated with breast cancer progression by gene expression analysis of predefined sets of neoplastic tissues.
    Cimino D; Fuso L; Sfiligoi C; Biglia N; Ponzone R; Maggiorotto F; Russo G; Cicatiello L; Weisz A; Taverna D; Sismondi P; De Bortoli M
    Int J Cancer; 2008 Sep; 123(6):1327-38. PubMed ID: 18561318
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
    Feng YM; Gao G; Zhang F; Chen H; Wan YF; Li XQ
    Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(39):2749-55. PubMed ID: 17199993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered antisense-to-sense transcript ratios in breast cancer.
    Maruyama R; Shipitsin M; Choudhury S; Wu Z; Protopopov A; Yao J; Lo PK; Bessarabova M; Ishkin A; Nikolsky Y; Liu XS; Sukumar S; Polyak K
    Proc Natl Acad Sci U S A; 2012 Feb; 109(8):2820-4. PubMed ID: 21098291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer.
    Jézéquel P; Campone M; Gouraud W; Guérin-Charbonnel C; Leux C; Ricolleau G; Campion L
    Breast Cancer Res Treat; 2012 Feb; 131(3):765-75. PubMed ID: 21452023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Co-expression of key gene modules and pathways of human breast cancer cell lines.
    Wu Y; Liu F; Luo S; Yin X; He D; Liu J; Yue Z; Song J
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31285391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic significance in breast cancer of a gene signature capturing stromal PDGF signaling.
    Frings O; Augsten M; Tobin NP; Carlson J; Paulsson J; Pena C; Olsson E; Veerla S; Bergh J; Ostman A; Sonnhammer EL
    Am J Pathol; 2013 Jun; 182(6):2037-47. PubMed ID: 23583284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes.
    Győrffy B; Bottai G; Fleischer T; Munkácsy G; Budczies J; Paladini L; Børresen-Dale AL; Kristensen VN; Santarpia L
    Int J Cancer; 2016 Jan; 138(1):87-97. PubMed ID: 26174627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An integrative approach to characterize disease-specific pathways and their coordination: a case study in cancer.
    Xu M; Kao MC; Nunez-Iglesias J; Nevins JR; West M; Zhou XJ
    BMC Genomics; 2008; 9 Suppl 1(Suppl 1):S12. PubMed ID: 18366601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High GINS2 transcript level predicts poor prognosis and correlates with high histological grade and endocrine therapy resistance through mammary cancer stem cells in breast cancer patients.
    Zheng M; Zhou Y; Yang X; Tang J; Wei D; Zhang Y; Jiang JL; Chen ZN; Zhu P
    Breast Cancer Res Treat; 2014 Nov; 148(2):423-36. PubMed ID: 25348432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification and evaluation of network modules for the prognosis of basal-like breast cancer.
    Hallett RM; Cockburn JG; Li B; Dvorkin-Gheva A; Hassell JA; Bane A
    Oncotarget; 2015 Jul; 6(19):17713-24. PubMed ID: 25991675
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
    Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
    BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In-depth characterization of breast cancer tumor-promoting cell transcriptome by RNA sequencing and microarrays.
    Callari M; Guffanti A; Soldà G; Merlino G; Fina E; Brini E; Moles A; Cappelletti V; Daidone MG
    Oncotarget; 2016 Jan; 7(1):976-94. PubMed ID: 26556871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of CHCHD2P9 and ZNF204P in breast cancer: exploring their expression patterns and associations with malignancy-related genes.
    Rastegari M; Sazegar H; Doosti A
    Mol Biol Rep; 2024 Jun; 51(1):707. PubMed ID: 38824255
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.